Company intelligence / Profile preview

Michelson Diagnostics

Maidstone, England, United Kingdomvivosight.com ↗

Ownership: Private
Development stage: Commercial

Overview

Michelson Diagnostics has commercialized the VivoSight Dx OCT system for non-invasive skin imaging. Their technology is used in clinical dermatology and research settings to aid in the assessment of skin pathology and monitor therapy effectiveness. The product line has been cited in over 350 publications.[1][6] No drug or therapeutic clinical trial results are applicable as this is a device/platform company.

Therapeutic areas: OncologyDermatology
Modalities: DeviceOptical imaging system (Optical Coherence Tomography)
Industry: Medical Imaging

Beyond the preview

Go deeper on Michelson Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Michelson Diagnostics.

Explore the full profile